Crossmark

A novel likely pathogenic variant in the mitochondrial ribosomal protein L44 (MRPL44) associated with hypertrophic cardiomyopathy in Tunisian patients

Crossref DOI link: https://doi.org/10.1007/s11033-025-10556-6

Published Online: 2025-05-22

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gargouri, Rania

Ammous-Boukhris, Nihel

Hssairi, Manel

Mosbah, Amor

Jabeur, Mariem

Feki, Wiem

Mnif, Zeineb

Mokdad-Gargouri, Raja

Abid, Leila

Gargouri, Lamia
License Information

Text and Data Mining valid from 2025-05-22

Version of Record valid from 2025-05-22
More Information

Article History

Received: 22 March 2025

Accepted: 29 April 2025

First Online: 22 May 2025

Declarations

:

: The study was approved by the ‘Institutional human ethics committee of the Faculty of Medicine of Sfax-Tunisia.

: All the study subjects gave prior written informed consent for blood samples collection.

: The authors declare no competing interests.

: Authors have no relevant financial or non-financial interests to disclose.

Document is current

Any future updates will be listed below